Lindsey Marie Hartley - 08 Dec 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: CFO
Signature: /s/ Marc Began, as attorney-in-fact for Lindsey Hartley
Issuer symbol: AXGN
Transactions as of: 08 Dec 2025
Net transactions value: -$108,605
Form type: 4
Filing time: 10 Dec 2025, 17:18:45 UTC
Previous filing: 16 May 2025
Next filing: 17 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hartley Lindsey Marie	CFO	13631 PROGRESS BLVD., SUITE 400, ALACHUA	/s/ Marc Began, as attorney-in-fact for Lindsey Hartley	10 Dec 2025	0002068693

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$304,400	+20,000	+96%	$15.22	40,763	08 Dec 2025	Direct
transaction	AXGN	Common Stock	Options Exercise	$41,000	+5,000	+12%	$8.20	45,763	08 Dec 2025	Direct
transaction	AXGN	Common Stock	Sale	$363,935	-11,533	-25%	$31.56	34,230	08 Dec 2025	Direct
transaction	AXGN	Common Stock	Sale	$90,069	-2,854	-8.3%	$31.56	31,376	08 Dec 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Employee Stock Option (right to purchase)	Options Exercise	$0	-20,000	-100%	$0.000000	0	08 Dec 2025	Common Stock	20,000	$15.22	Direct	F1
transaction	AXGN	Employee Stock Option (right to purchase)	Options Exercise	$0	-5,000	-67%	$0.000000	2,500	08 Dec 2025	Common Stock	5,000	$8.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
F2	All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.